The Duke-Margolis Institute for Health Policy and the U.S. Food and Drug Administration's (FDA) Quantitative Medicine Center of Excellence (QM CoE) will co-convene a virtual workshop to inform the establishment of the Quantitative Medicine Innovation Network (QMIN).